Dermapharm Holding SEFRA:DMP 87 Dividend Payout Ratio is 0.00 as of Mar. 2026. GuruFocus rates FRA:DMP with a GF Score™ of 87/100 and a GF Value™ of €39.11 (Modestly Overvalued). The stock has 9 warning signs investors should review. Among 444 Drug Manufacturers companies, Dermapharm Holding SE ranks better than 56.76% on this metric.
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Dermapharm Holding SE's Dividend Payout Ratio for the
months ended in Mar. 2026 was 0.00.
The historical rank and industry rank for Dermapharm Holding SE's Dividend Payout Ratio or its related term are showing as below:
FRA:DMP'
s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.23 Med: 0.48 Max: 0.97
Current: 0.34
During the past 13 years, the highest Dividend Payout Ratio of Dermapharm Holding SE was 0.97. The lowest was 0.23. And the median was 0.48.
FRA:DMP's Dividend Payout Ratio is ranked better than 56.76% of 444
companies
in the Drug Manufacturers industry
Industry Median: 0.375
vs FRA:DMP: 0.34
During the past 13 years, the highest Trailing Annual Dividend Yield of Dermapharm Holding SE was 6.02%. The lowest was 0.99%. And the median was 2.32%.
During the past 12 months, Dermapharm Holding SE's average Dividends Per Share Growth Rate was 2.30% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was -25.40% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was -0.40% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Dermapharm Holding SE was 41.30% per year. The lowest was -25.40% per year. And the median was 4.75% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Dermapharm Holding SE (FRA:DMP) Dividend Payout Ratio Explanation
In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Dermapharm Holding SE Dividend Payout Ratio Related Terms
Dermapharm Holding SE Dividend Payout Ratio Historical Data
* Premium members only.
The historical data trend for Dermapharm Holding SE's Dividend Payout Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:DMP vs ZTS, UTHR, VTRS: Dividend Payout Ratio Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Dermapharm Holding SE's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dermapharm Holding SE Dividend Payout Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Dermapharm Holding SE's Dividend Payout Ratio distribution charts can be found below:
* The bar in red indicates where Dermapharm Holding SE's Dividend Payout Ratio falls into.
Dermapharm Holding SE Dividend Payout Ratio Calculation
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.
Dermapharm Holding SE's Dividend Payout Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dermapharm Holding SE (FRA:DMP) has a Dividend Payout Ratio of 0.00 as of Mar. 2026. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Dermapharm Holding SE and its competitors. Over the past decade, Dermapharm Holding SE's Dividend Payout Ratio has ranged from 0.23 to 0.97. According to the industry distribution chart, Dermapharm Holding SE ranks #192 out of 444 companies in the Drug Manufacturers industry, placing it in the top 43.2%.
Is Dermapharm Holding SE's Dividend Payout Ratio too high?
Dermapharm Holding SE's current Dividend Payout Ratio is 0.00. Over the past 10 years, this metric has ranged from a low of 0.23 to a high of 0.97. Based on the distribution chart, Dermapharm Holding SE ranks #192 out of 444 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Dermapharm Holding SE has a GF Score™ of 87/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Dermapharm Holding SE's Dividend Payout Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Dermapharm Holding SE ranks #192 out of 444 companies for Dividend Payout Ratio. This puts Dermapharm Holding SE in the upper half of its industry. The industry median Dividend Payout Ratio is 0.38. Historically, Dermapharm Holding SE's own Dividend Payout Ratio has ranged from 0.23 to 0.97 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Payout Ratio for a Drug Manufacturers company?
The median Dividend Payout Ratio among Drug Manufacturers companies is 0.38, based on 444 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Payout Ratio mean?
A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Dermapharm Holding SE and its competitors. For the Drug Manufacturers industry, the median Dividend Payout Ratio is 0.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dermapharm Holding SE's current Dividend Payout Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dermapharm Holding SE stock overvalued right now?
Based on GuruFocus' analysis, Dermapharm Holding SE (FRA:DMP) is currently considered Modestly Overvalued. The stock's GF Value™ is €39.11, compared to a current price of €46.25 — trading 18.3% above its estimated fair value. The current Dividend Payout Ratio is 0.00. Dermapharm Holding SE's overall GF Score™ is 87/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Payout Ratio calculated?
Dividend Payout Ratio is calculated from a company's financial statements. For Dermapharm Holding SE (FRA:DMP), the current Dividend Payout Ratio is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dermapharm Holding SE (FRA:DMP) Overvalued in 2026?
Based on GuruFocus' analysis, Dermapharm Holding SE stock appears to be overvalued.
The current stock price of €46.25 is trading 18.3% above its estimated GF Value™ of €39.11.
GuruFocus considers Dermapharm Holding SE to be Modestly Overvalued.
Key valuation signals for FRA:DMP:
Dividend Payout Ratio: 0.00
GF Value™: €39.11 vs. price of €46.25 (18.3% above fair value)
No single metric tells the full story. See the FRA:DMP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dermapharm Holding SE manufactures patent-free branded pharmaceuticals for selected therapy fields, over-the-counter drugs, and natural remedies. The portfolio of the company includes cosmetics, nutritional supplements, and diet and medical devices. Business operating segments include Branded pharmaceuticals, which drive key revenue, Other healthcare products, and Parallel import business. The Branded pharmaceuticals segment covers numerous product areas through a wide variety of items sold under reputable brand names.
87GF Score
Get the complete analysis for FRA:DMP
Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:DMP has been successfully added to your 
